Radiopharmaceuticals for NUC MED - do for OY4 :-( line item compliance rpoc vaccine mandate

Ended Awarded Last action

Contract number
36C25022N0185
Awardee
Awarding agency
Obligated
$44,320

Award facts

Contract value 5% obligated
  • $539,927.14 Current, with exercised options
  • $864,284.58 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Lima, OH 45801, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · Decrease for closeout of OY4 radiopharmaceuticals for NUC MED - do for OY4 :-( line item compliance rpoc vaccine mandate -$81,680
Original award $126,000

About this award

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 10 (VISN 10), awarded a delivery order contract to Schaaf Drugs, LLC, doing business as Heartlight Pharmacy Services, for the provision of radiopharmaceuticals for nuclear medicine services. The contract, valued at $864,284.58, is structured as a firm fixed-price delivery order with an ultimate completion date of January 5, 2023, and was awarded on January 6, 2022. The work will be performed in Lima, Ohio. This delivery order represents a continuation of an existing indefinite delivery contract vehicle and does not utilize a set-aside designation. The contract includes language referencing compliance matters related to vaccine mandates and closeout procedures for Option Year 4.

Schaaf Drugs, LLC specializes in supplying unit dose radiopharmaceuticals and radioactive isotopes essential for diagnostic imaging and nuclear medicine treatment programs across the VA healthcare system. The company, registered in the System for Award Management since 2010, has consistently served as the prime contractor for radiopharmaceutical procurement for VISN 10, which encompasses Ohio and Indiana. The radiopharmaceutical products delivered under this contract support critical diagnostic and therapeutic procedures for veterans, with the company holding multiple indefinite delivery contracts with potential values ranging from approximately $340,000 to $3.9 million. As a specialized supplier in this niche pharmaceutical market, Schaaf Drugs has established itself as a key provider of essential nuclear medicine supplies to the VA's veteran healthcare delivery system.

Quick answers

Who was awarded contract 36C25022N0185?

36C25022N0185 was awarded to Schaaf Drugs, LLC by Veterans Integrated Service Network 10 (Veterans Health Administration) on January 6, 2022.

How much is contract 36C25022N0185 worth?

The government has obligated $44,320 on 36C25022N0185. Its current value, with exercised options, is $539,927. Its potential value, with all options, is $864,285.

Is contract 36C25022N0185 an order under another contract?

Yes. 36C25022N0185 is a delivery order under 36C25018D0047, an indefinite delivery contract.

Was contract 36C25022N0185 competed?

The extent of competition for 36C25022N0185 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award